Schering, Mylan Settle Generic Clarinex Patent Case
Mylan Pharmaceuticals Inc. and Schering Corp. have reached an agreement in patent litigation over Clarinex that will allow the generics maker to begin selling a copycat version of the allergy medicine...To view the full article, register now.
Already a subscriber? Click here to view full article